Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Beijing Tong Ren Tang Chinese Medicine Co stock

3613.HK
HK0000145638
A1XDB1

Price

8.23 HKD
Today +/-
+0.01 HKD
Today %
+0.98 %

Beijing Tong Ren Tang Chinese Medicine Co stock price

HKD
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Beijing Tong Ren Tang Chinese Medicine Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Beijing Tong Ren Tang Chinese Medicine Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Beijing Tong Ren Tang Chinese Medicine Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Beijing Tong Ren Tang Chinese Medicine Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Beijing Tong Ren Tang Chinese Medicine Co Stock Price History

DateBeijing Tong Ren Tang Chinese Medicine Co Price
2/21/20258.23 HKD
2/20/20258.15 HKD
2/19/20258.14 HKD
2/18/20258.21 HKD
2/17/20258.25 HKD
2/14/20258.33 HKD
2/13/20258.15 HKD
2/12/20258.19 HKD
2/11/20258.19 HKD
2/10/20258.33 HKD
2/7/20258.30 HKD
2/6/20258.34 HKD
2/5/20258.20 HKD
2/4/20258.17 HKD
2/3/20258.30 HKD
1/28/20258.30 HKD
1/27/20258.31 HKD

Beijing Tong Ren Tang Chinese Medicine Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Beijing Tong Ren Tang Chinese Medicine Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Beijing Tong Ren Tang Chinese Medicine Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Beijing Tong Ren Tang Chinese Medicine Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Beijing Tong Ren Tang Chinese Medicine Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Beijing Tong Ren Tang Chinese Medicine Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Beijing Tong Ren Tang Chinese Medicine Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Beijing Tong Ren Tang Chinese Medicine Co’s growth potential.

Beijing Tong Ren Tang Chinese Medicine Co Revenue, EBIT and net profit per share

DateBeijing Tong Ren Tang Chinese Medicine Co RevenueBeijing Tong Ren Tang Chinese Medicine Co EBITBeijing Tong Ren Tang Chinese Medicine Co Net Income
2026e2.05 B HKD957.7 M HKD751.38 M HKD
2025e1.89 B HKD822.28 M HKD687.34 M HKD
2024e1.66 B HKD690.89 M HKD572.07 M HKD
20231.52 B HKD618.39 M HKD540.39 M HKD
20221.73 B HKD811.58 M HKD645.88 M HKD
20211.56 B HKD778.46 M HKD607.84 M HKD
20201.32 B HKD669.4 M HKD542.46 M HKD
20191.43 B HKD651.99 M HKD556.12 M HKD
20181.51 B HKD698.01 M HKD580.72 M HKD
20171.27 B HKD597.68 M HKD489.97 M HKD
20161.08 B HKD527.5 M HKD420.32 M HKD
2015970.48 M HKD452.48 M HKD354.25 M HKD
2014761.05 M HKD343.52 M HKD287.12 M HKD
2013614 M HKD252.9 M HKD220 M HKD
2012333 M HKD113.7 M HKD155.9 M HKD
2011196.7 M HKD23.9 M HKD58.7 M HKD

Beijing Tong Ren Tang Chinese Medicine Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B HKD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B HKD)NET INCOME (M HKD)NET INCOME GROWTH (%)DIV. (HKD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e
0.20.330.610.760.971.081.271.511.431.321.561.731.521.661.892.05
-69.9084.3823.9427.4611.7516.7019.60-5.35-8.1718.3311.25-11.968.9213.678.69
66.8470.8768.4071.3570.1073.3472.4171.2570.6772.4071.9266.4468.7063.0755.4851.05
0.130.240.420.540.680.80.921.081.010.951.121.151.05000
58155220287354420489580556542607645540572687751
-167.2441.9430.4523.3418.6416.4318.61-4.14-2.5211.996.26-16.285.9320.109.32
----------------
----------------
402.9600749.3830835.99837.1837.1837.1837.1837.1837.1837.1837.1000
----------------
Details

Keystats

Revenue and Growth

The Beijing Tong Ren Tang Chinese Medicine Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Beijing Tong Ren Tang Chinese Medicine Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B HKD)RECEIVABLES (M HKD)OTHER REC. (M HKD)INVENTORIES (B HKD)OTHER CURRENT LIAB. (M HKD)CURRENT ASSETS (B HKD)TANGIBLE ASSETS (M HKD)LONG-T. INVEST. (M HKD)LONG-T. REC. (M HKD)INTANGIBLE ASSETS (M HKD)GOODWILL (M HKD)OTHER NON-CURRENT ASSETS (M HKD)NON-CURRENT ASSETS (M HKD)TOTAL ASSETS (B HKD)LIABILITIESCOMMON STOCK (M HKD)ADDITIONAL PAID-IN CAPITAL (M HKD)RETAINED EARNINGS (B HKD)OTHER EQUITY (M HKD)UNREAL. GAINS/LOSSES (M HKD)EQUITY (B HKD)LIABILITIES (M HKD)PROVISIONS (M HKD)OTHER SHORT-TERM LIAB. (M HKD)SHORT-TERM DEBTS (M HKD)LONG-TERM DEBT PORTION (M HKD)SHORT-TERM REC. (M HKD)LONG-T. LIAB. (M HKD)DEFERRED TAXES (M HKD)OTHER LIAB. (M HKD)LONG-T. LIABILITIES (M HKD)DEBT (M HKD)TOTAL CAPITAL (B HKD)
2011201220132014201520162017201820192020202120222023
                         
0.160.240.921.031.281.581.92.271.971.852.282.242.38
18.322.8112.7127.38171.12144.58170.77176.93313.04546.45526.48923.23395.24
3.61.11.11.111.111.111.111.111.110.970.9718.7727.74
0.060.080.10.120.160.180.240.240.320.50.430.471.01
14.1173.819.136.2241.4448.8249.6958.4543.1143.0141.9327.3330.99
0.260.511.161.321.651.962.352.752.642.933.283.683.84
163.4110.6212.6262.54262.76257.23265.54289.17395.37392.25411.81405.07436.81
1.924.314.425.8623.0833.1236.0835.6529.5323.8763.3662.6159.8
000000000016.0618.770
000011.9231.8629.5872.4960.6754.8460.9559.7156.39
000049.4249.4249.42000000
59.420.824.524.4925.6126.5425.1427.328.9413.0622.0514.8137.12
224.7155.7251.5312.89372.79398.18405.77424.62494.51484.02574.23560.98590.12
0.490.671.411.632.032.352.763.173.143.423.854.244.43
                         
201.4201.4415415938.79938.79938.79938.79938.79938.79938.79938.79938.79
3.93.9452.40000000000
0.120.280.40.620.891.21.561.981.742.082.482.692.95
12.114.56.1-2.55-14.64-18.83-6.51-15.6-18.11-5.17-4.51-24.56-24.9
0000000000000
0.340.491.271.031.822.122.492.912.663.023.423.63.87
20.84446.838.1635.3536.2452.6851.7265.9174.1334.6153.71422.39
10.811.522.332.7241.6452.1361.8162.3674.7662.2788.4577.0365.22
19.741.82720.1335.7334.5232.9726.69126.7639.3536.81145.4931.3
0000000000000
00000000.1739.6540.8653.242.3556.42
51.397.396.191.01112.72122.89147.45140.93307.08216.62213.06418.57575.33
00000.560.560.611.0560.2365.1575.2760.7375.39
4.73.84.24.684.794.144.424.875.385.77.157.188.44
20.2000000000-122.61-134.860
24.93.84.24.685.354.695.025.9365.670.84-40.19-66.9583.84
76.2101.1100.395.68118.07127.59152.48146.86372.68287.46172.87351.63659.16
0.420.61.371.131.932.252.653.053.033.33.593.964.53
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Beijing Tong Ren Tang Chinese Medicine Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Beijing Tong Ren Tang Chinese Medicine Co's financial health and stability.

Assets

Beijing Tong Ren Tang Chinese Medicine Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Beijing Tong Ren Tang Chinese Medicine Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Beijing Tong Ren Tang Chinese Medicine Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Beijing Tong Ren Tang Chinese Medicine Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M HKD)DEPRECIATION (M HKD)DEFERRED TAXES (M HKD)CHANGES IN WORKING CAPITAL (M HKD)NON-CASH ITEM (M HKD)PAID INTEREST (M HKD)PAID TAXES (M HKD)NET CASH FLOW FROM OPERATING ACTIVITIES (M HKD)CAPITAL EXPENDITURES (M HKD)CASH FLOW FROM INVESTING ACTIVITIES (M HKD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M HKD)INTEREST INCOME AND EXPENSES (M HKD)NET DEBT CHANGE (M HKD)NET CHANGE IN EQUITY (M HKD)CASH FLOW FROM FINANCING ACTIVITIES (M HKD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M HKD)TOTAL DIVIDENDS PAID (M HKD)NET CHANGE IN CASH FLOW (M HKD)FREE CASH FLOW (M HKD)SHARE-BASED COMPENSATION (M HKD)
201120122013201420152016201720182019202020212022
77198271355456532610720689685778825
101014172223263079786975
000000000000
-57-37-138-117-123-84-164-155-192-633-77-346
3814-4-10-1-3-4-17-25-146-7
000000004444
203333677395105133621113719
69185142244353467469577551116777547
-62-64-126-71-26-38-34-53-16-12-23-38
-36-63-475-72-68-309-381-597835506-265335
252-349-1-41-271-347-544852519-242373
000000000000
00000000-45-45-50-56
00699000000000
-14-14540-56-80-116-141-173-878-264-278-535
-14-14-58102-7-7-14-37-26-27-35
00-100-66-83-108-133-159-795-192-200-443
1811020410919637-47-200506369234330
7.2120.216.1173.32326.6429.46435.06524.46534.02103.17753.74508.94
000000000000

Beijing Tong Ren Tang Chinese Medicine Co stock margins

The Beijing Tong Ren Tang Chinese Medicine Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Beijing Tong Ren Tang Chinese Medicine Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Beijing Tong Ren Tang Chinese Medicine Co.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Beijing Tong Ren Tang Chinese Medicine Co's sales revenue. A higher gross margin percentage indicates that the Beijing Tong Ren Tang Chinese Medicine Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Beijing Tong Ren Tang Chinese Medicine Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Beijing Tong Ren Tang Chinese Medicine Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Beijing Tong Ren Tang Chinese Medicine Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Beijing Tong Ren Tang Chinese Medicine Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Beijing Tong Ren Tang Chinese Medicine Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Beijing Tong Ren Tang Chinese Medicine Co Margin History

Beijing Tong Ren Tang Chinese Medicine Co Gross marginBeijing Tong Ren Tang Chinese Medicine Co Profit marginBeijing Tong Ren Tang Chinese Medicine Co EBIT marginBeijing Tong Ren Tang Chinese Medicine Co Profit margin
2026e68.67 %46.69 %36.63 %
2025e68.67 %43.58 %36.43 %
2024e68.67 %41.59 %34.44 %
202368.67 %40.55 %35.44 %
202266.44 %46.88 %37.31 %
202171.95 %50.02 %39.06 %
202072.45 %50.89 %41.24 %
201970.69 %45.51 %38.82 %
201871.24 %46.11 %38.36 %
201772.39 %47.21 %38.7 %
201673.33 %48.65 %38.76 %
201570.16 %46.62 %36.5 %
201471.35 %45.14 %37.73 %
201368.4 %41.19 %35.83 %
201270.9 %34.14 %46.82 %
201167.01 %12.15 %29.84 %

Beijing Tong Ren Tang Chinese Medicine Co Stock Sales Revenue, EBIT, Earnings per Share

The Beijing Tong Ren Tang Chinese Medicine Co earnings per share therefore indicates how much revenue Beijing Tong Ren Tang Chinese Medicine Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Beijing Tong Ren Tang Chinese Medicine Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Tong Ren Tang Chinese Medicine Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Tong Ren Tang Chinese Medicine Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Tong Ren Tang Chinese Medicine Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Tong Ren Tang Chinese Medicine Co Revenue, EBIT and net profit per share

DateBeijing Tong Ren Tang Chinese Medicine Co Sales per ShareBeijing Tong Ren Tang Chinese Medicine Co EBIT per shareBeijing Tong Ren Tang Chinese Medicine Co Earnings per Share
2026e2.45 HKD0 HKD0.9 HKD
2025e2.25 HKD0 HKD0.82 HKD
2024e1.98 HKD0 HKD0.68 HKD
20231.82 HKD0.74 HKD0.65 HKD
20222.07 HKD0.97 HKD0.77 HKD
20211.86 HKD0.93 HKD0.73 HKD
20201.57 HKD0.8 HKD0.65 HKD
20191.71 HKD0.78 HKD0.66 HKD
20181.81 HKD0.83 HKD0.69 HKD
20171.51 HKD0.71 HKD0.59 HKD
20161.3 HKD0.63 HKD0.5 HKD
20151.16 HKD0.54 HKD0.42 HKD
20140.92 HKD0.41 HKD0.35 HKD
20130.82 HKD0.34 HKD0.29 HKD
20120.56 HKD0.19 HKD0.26 HKD
20110.49 HKD0.06 HKD0.15 HKD

Beijing Tong Ren Tang Chinese Medicine Co business model

Beijing Tong Ren Tang Chinese Medicine Co Ltd is one of the leading companies in the field of traditional Chinese medicine (TCM) and is headquartered in Beijing, China. The company was founded in 1669 and has a long history in the manufacturing of TCM products. The company has a versatile business model and is involved in various sectors. In addition to manufacturing TCM products, the company operates 30 retail stores in China and 24 internationally in countries such as the USA, Canada, Japan, and Singapore, to name a few. Tong Ren Tang also offers its products online and works with distributors and pharmacies worldwide. The company places great emphasis on quality and has invested in state-of-the-art production facilities in recent years to ensure the highest standards. Tong Ren Tang has not only improved TCM preparations but also produced a variety of dietary supplements, skincare products, herbal baths, and children's medications. TCM is a natural approach to treating diseases that dates back many centuries and is still popular among many people. Tong Ren Tang specializes in delivering TCM products of the highest quality. The products are manufactured under strict quality controls that ensure the purity and efficacy of the product. The company is known for its famous brand, "Tong Ren Tang," which is highly popular in China and around the world. Tong Ren Tang products are available in more than 50 countries worldwide and are appreciated by thousands of customers. In addition to their core competence in manufacturing TCM products and supplements, Tong Ren Tang has also developed other products, such as premium skincare products like Ginseng and Pearl Night Cream. To ensure effectiveness and safety, the company has been striving for centuries to achieve the highest standards by using high-quality and trusted raw materials. Tong Ren Tang is also committed to educating the public about the benefits of TCM and has conducted many radio advertisements and sponsored television shows through Pan-Asian channels in recent years. The company has also received various international awards and certifications such as GMP (Good Manufacturing Practice) and actively advocates for environmental protection and social responsibility. Overall, Beijing Tong Ren Tang is a unique company that seamlessly combines tradition and modern technology to produce top-quality TCM products. Tong Ren Tang's commitment to quality, effectiveness, and safety, as well as its promotion of the TCM industry, has helped expand understanding and access to TCM products worldwide. Beijing Tong Ren Tang Chinese Medicine Co is one of the most popular companies on Eulerpool.com.

Beijing Tong Ren Tang Chinese Medicine Co SWOT Analysis

Strengths

Beijing Tong Ren Tang Chinese Medicine Co Ltd has several strengths that contribute to its success in the Chinese medicine industry:

  • Established brand: Beijing Tong Ren Tang is a well-known and trusted brand with a long history dating back to 1669.
  • Quality products: The company is renowned for its high-quality Chinese medicine products, which are based on traditional formulas and use premium ingredients.
  • Extensive distribution network: Beijing Tong Ren Tang has a wide network of retail stores, clinics, and online platforms, enabling easy access to its products.
  • Strong research and development capabilities: The company invests in research and development to innovate and improve its product offerings.
  • Strong customer loyalty: The brand has a large base of loyal customers who trust and rely on its products.

Weaknesses

Despite its strengths, Beijing Tong Ren Tang also faces certain weaknesses:

  • Limited international presence: The company's operations and market are primarily focused on China, limiting its exposure to global markets.
  • Inefficient supply chain: Beijing Tong Ren Tang faces challenges in managing its supply chain, leading to occasional stock shortages.
  • Reliance on traditional methods: The company's adherence to traditional Chinese medicine practices may limit its ability to adapt to changing consumer preferences and demands.
  • Competition: The Chinese medicine industry is highly competitive, and Beijing Tong Ren Tang faces competition from both traditional and modern medicine providers.

Opportunities

Beijing Tong Ren Tang can capitalize on various opportunities to further enhance its position in the market:

  • Increasing demand for traditional medicine: As people show more interest in holistic and natural remedies, there is a growing market for traditional Chinese medicine.
  • Expansion into international markets: There is an opportunity for Beijing Tong Ren Tang to expand its presence beyond China by entering new international markets.
  • Research and development: Further investment in R&D can help the company develop new and improved products to meet evolving customer needs.
  • Partnerships and collaborations: Forming strategic partnerships with healthcare providers and distributors can enhance the company's reach and distribution capabilities.

Threats

Beijing Tong Ren Tang faces certain threats that may pose challenges to its growth and sustainability:

  • Regulatory hurdles: The Chinese medicine industry is subject to stringent regulations, and changes in regulations could impact the company's operations.
  • Counterfeit products: Beijing Tong Ren Tang's strong brand reputation makes it vulnerable to counterfeit products, which can harm the company's image and customer trust.
  • Healthcare reforms: Government policies and healthcare reforms may favor modern medicine over traditional practices, potentially affecting the demand for Chinese medicine.
  • Changing consumer preferences: Shifts in consumer preferences towards alternative medicine or other healthcare options may impact the demand for traditional Chinese medicine.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Beijing Tong Ren Tang Chinese Medicine Co Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Beijing Tong Ren Tang Chinese Medicine Co historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Beijing Tong Ren Tang Chinese Medicine Co shares outstanding

The number of shares was Beijing Tong Ren Tang Chinese Medicine Co in 2024 — This indicates how many shares 837.1 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Beijing Tong Ren Tang Chinese Medicine Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Beijing Tong Ren Tang Chinese Medicine Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Beijing Tong Ren Tang Chinese Medicine Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Beijing Tong Ren Tang Chinese Medicine Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Beijing Tong Ren Tang Chinese Medicine Co dividend history and estimates

In 2024, Beijing Tong Ren Tang Chinese Medicine Co paid a dividend amounting to 0.66 HKD. Dividend means that Beijing Tong Ren Tang Chinese Medicine Co distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Beijing Tong Ren Tang Chinese Medicine Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Beijing Tong Ren Tang Chinese Medicine Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Beijing Tong Ren Tang Chinese Medicine Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Beijing Tong Ren Tang Chinese Medicine Co Dividend History

DateBeijing Tong Ren Tang Chinese Medicine Co Dividend
2026e0.36 HKD
2025e0.36 HKD
2024e0.36 HKD
20230.33 HKD
20220.53 HKD
20210.24 HKD
20200.23 HKD
20190.95 HKD
20180.19 HKD
20170.16 HKD
20160.13 HKD
20150.1 HKD
20140.08 HKD

Beijing Tong Ren Tang Chinese Medicine Co dividend payout ratio

In 2024, Beijing Tong Ren Tang Chinese Medicine Co had a payout ratio of 49.16%. The payout ratio indicates the percentage of the company's profits that Beijing Tong Ren Tang Chinese Medicine Co distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Beijing Tong Ren Tang Chinese Medicine Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Beijing Tong Ren Tang Chinese Medicine Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Beijing Tong Ren Tang Chinese Medicine Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Beijing Tong Ren Tang Chinese Medicine Co Payout Ratio History

DateBeijing Tong Ren Tang Chinese Medicine Co Payout ratio
2026e49.81 %
2025e54.53 %
2024e49.16 %
202345.75 %
202268.69 %
202133.05 %
202035.49 %
2019143 %
201827.39 %
201727.34 %
201625.89 %
201523.6 %
201423.13 %
201345.75 %
201245.75 %
201145.75 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Beijing Tong Ren Tang Chinese Medicine Co.

Beijing Tong Ren Tang Chinese Medicine Co latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20170.28 HKD0.28 HKD (1.67 %)2017 Q4
6/30/20170.33 HKD0.31 HKD (-5.6 %)2017 Q2
1

Beijing Tong Ren Tang Chinese Medicine Co shareholders

%
Name
Stocks
Change
Date
38.05280 % Tong Ren Tang Technologies Co Ltd318,540,000012/31/2023
33.62322 % Beijing Tongrentang Co Ltd281,460,000012/31/2023
1.62336 % E Fund Management Co. Ltd.13,589,1772,437,3296/30/2024
0.78759 % The Vanguard Group, Inc.6,592,89809/30/2024
0.53494 % Value Partners Ltd.4,478,000-88,0006/30/2024
0.47951 % Bosera Asset Management Co., Ltd.4,014,000-14,0006/30/2024
0.46601 % BlackRock Institutional Trust Company, N.A.3,901,00011,0009/30/2024
0.42062 % Dimensional Fund Advisors, L.P.3,521,00027,0008/31/2024
0.27906 % China Merchants Fund Management Co. Ltd.2,336,000-3,892,0006/30/2024
0.09214 % BlackRock Advisors (UK) Limited771,337-2,0009/30/2024
1
2
3
4
5
...
7

Beijing Tong Ren Tang Chinese Medicine Co Executives and Management Board

Mr. Fei Chen

(52)
Beijing Tong Ren Tang Chinese Medicine Co Deputy General Manager, Executive Director (since 2020)
Compensation 1.1 M HKD

Mr. Ngai Chi Chan

(50)
Beijing Tong Ren Tang Chinese Medicine Co Non-Executive Independent Director
Compensation 240,000 HKD

Mr. Yok Sing Tsang

(74)
Beijing Tong Ren Tang Chinese Medicine Co Non-Executive Independent Director
Compensation 240,000 HKD

Mr. Hai Ou Gu

(58)
Beijing Tong Ren Tang Chinese Medicine Co Executive Chairman of the Board (since 2023)

Mr. Jin Yu

(54)
Beijing Tong Ren Tang Chinese Medicine Co Chief Executive Officer, Executive Director (since 2023)
1
2

Beijing Tong Ren Tang Chinese Medicine Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,450,210,350,880,810,84
SupplierCustomer0,06-0,430,110,510,510,66
1

Most common questions regarding Beijing Tong Ren Tang Chinese Medicine Co

What values and corporate philosophy does Beijing Tong Ren Tang Chinese Medicine Co represent?

Beijing Tong Ren Tang Chinese Medicine Co Ltd represents a strong commitment to traditional Chinese medicine (TCM) and the values of quality, integrity, and innovation. With a rich history dating back to 1669, the company has been dedicated to providing authentic TCM products and services globally. Beijing Tong Ren Tang embraces a corporate philosophy centered around the preservation and advancement of TCM, while upholding strict standards in manufacturing and research. The company's emphasis on customer satisfaction, scientific advancements, and cultural heritage has positioned it as a leading provider of high-quality Chinese medicine products in the market.

In which countries and regions is Beijing Tong Ren Tang Chinese Medicine Co primarily present?

Beijing Tong Ren Tang Chinese Medicine Co Ltd primarily operates in China, its country of origin. As one of the oldest and most renowned traditional Chinese medicine (TCM) companies, its presence is mainly focused within the mainland. With a rich history dating back over 350 years, Beijing Tong Ren Tang has expanded its reach beyond China, establishing subsidiaries and distribution networks in various countries and regions worldwide. However, its core operations remain centered in China, where it continues to be a leading provider of high-quality TCM products and services.

What significant milestones has the company Beijing Tong Ren Tang Chinese Medicine Co achieved?

Some significant milestones achieved by Beijing Tong Ren Tang Chinese Medicine Co Ltd include the company's establishment in 1669 during the Qing Dynasty, making it one of the oldest Chinese medicine companies in operation. With a rich history spanning over three centuries, Beijing Tong Ren Tang has become a renowned and trusted brand globally for traditional Chinese medicine products. The company has received numerous accolades and awards for its commitment to quality and authenticity. It has also expanded its presence internationally, with branches in various countries. Beijing Tong Ren Tang continues to innovate and uphold the principles of traditional Chinese medicine, contributing to the health and well-being of individuals worldwide.

What is the history and background of the company Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is a renowned company with a rich history and background. Established in 1669, it has a legacy of over 350 years in the Chinese medicine industry. As one of the oldest and most prestigious traditional Chinese medicine companies, Beijing Tong Ren Tang has become synonymous with excellence in herbal medicine and healthcare products. With a mission to preserve and promote the wisdom of traditional Chinese medicine, the company has expanded globally, serving customers worldwide. Today, Beijing Tong Ren Tang continues to be a trusted name, offering high-quality, authentic herbal products derived from centuries of expertise in Chinese medicine.

Who are the main competitors of Beijing Tong Ren Tang Chinese Medicine Co in the market?

Beijing Tong Ren Tang Chinese Medicine Co Ltd faces competition from several companies in the market. Some of its main competitors include Shanghai Traditional Chinese Medicines Group, China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, and Tasly Pharmaceutical Group Co Ltd. These companies also operate in the traditional Chinese medicine industry and offer similar products and services, posing a challenge to Beijing Tong Ren Tang Chinese Medicine Co Ltd's market position.

In which industries is Beijing Tong Ren Tang Chinese Medicine Co primarily active?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is primarily active in the pharmaceutical and healthcare industries.

What is the business model of Beijing Tong Ren Tang Chinese Medicine Co?

The business model of Beijing Tong Ren Tang Chinese Medicine Co Ltd is focused on the production and distribution of traditional Chinese medicine products. With a rich history dating back to 1669, the company applies stringent quality control measures to ensure the effectiveness and safety of its remedies. Beijing Tong Ren Tang is recognized for its proprietary knowledge in herbal medicine, providing a wide range of products including herbal decoctions, health tonics, and external use formulations. By adhering to traditional Chinese medicine principles, the company aims to promote overall health and wellbeing through its products. Beijing Tong Ren Tang Chinese Medicine Co Ltd continues to uphold its reputation as a leading provider of trusted and authentic Chinese medicine worldwide.

What is the P/E ratio of Beijing Tong Ren Tang Chinese Medicine Co 2025?

The Beijing Tong Ren Tang Chinese Medicine Co P/E ratio is 10.02.

What is the P/S ratio of Beijing Tong Ren Tang Chinese Medicine Co 2025?

The Beijing Tong Ren Tang Chinese Medicine Co P/S ratio is 3.65.

What is the Quality Investing of Beijing Tong Ren Tang Chinese Medicine Co?

The Quality Investing for Beijing Tong Ren Tang Chinese Medicine Co is 8/10.

What is the revenue of Beijing Tong Ren Tang Chinese Medicine Co 2025?

The expected Beijing Tong Ren Tang Chinese Medicine Co revenue is 1.89 B HKD.

How high is the profit of Beijing Tong Ren Tang Chinese Medicine Co 2025?

The expected Beijing Tong Ren Tang Chinese Medicine Co profit is 687.34 M HKD.

What is the business model of Beijing Tong Ren Tang Chinese Medicine Co

Beijing Tong Ren Tang Chinese Medicine Co Ltd is one of the largest and most well-known companies for Chinese medicine worldwide. Founded in 1669, the company has a long and rich history. Today, Beijing Tong Ren Tang operates in more than 50 countries and offers a variety of products and services related to Chinese medicine. The core business of Beijing Tong Ren Tang is in the field of traditional Chinese medicine. The company produces and distributes traditional herbal medicine, pharmaceuticals, and dietary supplements. High-quality natural raw materials are used and processed according to traditional methods. The products are offered worldwide through a network of distribution partners in pharmacies, drugstores, and online shops. In addition to the production of Chinese medicine, Beijing Tong Ren Tang also offers a variety of healthcare services. Traditional examination methods and diagnostic procedures are used to analyze the body's health condition and create individual therapy plans. Through close cooperation with doctors and clinics in China and other countries, patients can receive comprehensive care. Another significant aspect of Beijing Tong Ren Tang is the promotion of Chinese medicine culture and education. The company organizes workshops, seminars, and courses to train professionals and those interested in Chinese medicine. Additionally, Beijing Tong Ren Tang aims to promote Chinese culture and its medical traditions worldwide. Through research and development, Beijing Tong Ren Tang continuously works on exploring new healing methods and developing innovative products. Modern scientific knowledge is combined with the wisdom of traditional Chinese medicine. The goal is to provide patients with the best possible therapy and treatment. Overall, Beijing Tong Ren Tang's business model is focused on sustainable and long-term development. The company emphasizes high-quality products, tradition and innovation, and close collaboration with customers and partners worldwide. The goal of Beijing Tong Ren Tang is to promote health and well-being through the application of Chinese medicine and to promote Chinese culture.

What is the Beijing Tong Ren Tang Chinese Medicine Co dividend?

Beijing Tong Ren Tang Chinese Medicine Co pays a dividend of 0.53 HKD distributed over payouts per year.

How often does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?

The dividend cannot currently be calculated for Beijing Tong Ren Tang Chinese Medicine Co or the company does not pay out a dividend.

What is the Beijing Tong Ren Tang Chinese Medicine Co ISIN?

The ISIN of Beijing Tong Ren Tang Chinese Medicine Co is HK0000145638.

What is the Beijing Tong Ren Tang Chinese Medicine Co WKN?

The WKN of Beijing Tong Ren Tang Chinese Medicine Co is A1XDB1.

What is the Beijing Tong Ren Tang Chinese Medicine Co ticker?

The ticker of Beijing Tong Ren Tang Chinese Medicine Co is 3613.HK.

How much dividend does Beijing Tong Ren Tang Chinese Medicine Co pay?

Over the past 12 months, Beijing Tong Ren Tang Chinese Medicine Co paid a dividend of 0.33 HKD . This corresponds to a dividend yield of about 4.01 %. For the coming 12 months, Beijing Tong Ren Tang Chinese Medicine Co is expected to pay a dividend of 0.36 HKD.

What is the dividend yield of Beijing Tong Ren Tang Chinese Medicine Co?

The current dividend yield of Beijing Tong Ren Tang Chinese Medicine Co is 4.01 %.

When does Beijing Tong Ren Tang Chinese Medicine Co pay dividends?

Beijing Tong Ren Tang Chinese Medicine Co pays a quarterly dividend. This is distributed in the months of November, June, July, July.

How secure is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co paid dividends every year for the past 13 years.

What is the dividend of Beijing Tong Ren Tang Chinese Medicine Co?

For the upcoming 12 months, dividends amounting to 0.36 HKD are expected. This corresponds to a dividend yield of 4.37 %.

In which sector is Beijing Tong Ren Tang Chinese Medicine Co located?

Beijing Tong Ren Tang Chinese Medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beijing Tong Ren Tang Chinese Medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beijing Tong Ren Tang Chinese Medicine Co from 6/24/2024 amounting to 0.33 HKD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Beijing Tong Ren Tang Chinese Medicine Co pay the last dividend?

The last dividend was paid out on 6/24/2024.

What was the dividend of Beijing Tong Ren Tang Chinese Medicine Co in the year 2024?

In the year 2024, Beijing Tong Ren Tang Chinese Medicine Co distributed 0.33 HKD as dividends.

In which currency does Beijing Tong Ren Tang Chinese Medicine Co pay out the dividend?

The dividends of Beijing Tong Ren Tang Chinese Medicine Co are distributed in HKD.

All fundamentals about Beijing Tong Ren Tang Chinese Medicine Co

Our stock analysis for Beijing Tong Ren Tang Chinese Medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beijing Tong Ren Tang Chinese Medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.